Literature DB >> 21276120

Regulation of costimulatory signal in maternal-fetal immune tolerance.

Li-Ping Jin1, Deng-Xuan Fan, Da-Jin Li.   

Abstract

A pregnancy is associated with modifications in the immune status of the mother, but the mechanisms are not well understood. Several observations have indicated that CD28/CTLA-4 and B7-1/B7-2 are involved in the maternal-fetal immune regulation. This review aims to recapitulate our current knowledge concerning the role of CD28/CTLA-4 and B7-1/B7-2 in maternal-fetal immune regulation. Several studies suggest that up-regulation of B7-2 and/or CD28 and/or down-regulation of CTLA-4 are correlated with the occurrence of pregnancy loss. Therefore, an accurate expression of costimulatory molecules at the maternal-fetal interface may ensure that the decidual cells do not elicit a 'danger' signal to the maternal immune system, perhaps instead contributing to the establishment of immune tolerance in vivo. It is showed that costimulation blockade with anti-B7 mAbs results in altered allogeneic T-cell response and overcomes increased maternal rejection to the fetus, which improves fetus growth in the abortion-prone system. These findings suggest that the anti-B7-treated T cells not only function as potent suppresser cells but also exert immunoregulatory effect on the maternal T cells. This procedure might be potentially useful to immunotherapy for human recurrent spontaneous abortion.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21276120     DOI: 10.1111/j.1600-0897.2010.00982.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  8 in total

1.  Maternal HLA panel-reactive antibodies in early gestation positively correlate with chronic chorioamnionitis: evidence in support of the chronic nature of maternal anti-fetal rejection.

Authors:  JoonHo Lee; Roberto Romero; Yi Xu; Jung-Sun Kim; Ji Young Park; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Sonia S Hassan; Chong Jai Kim
Journal:  Am J Reprod Immunol       Date:  2011-09-27       Impact factor: 3.886

Review 2.  Developing Cures: Targeting Ontogenesis in Cancer.

Authors:  Victor T G Lin; Hawley C Pruitt; Rajeev S Samant; Lalita A Shevde
Journal:  Trends Cancer       Date:  2017-01-27

3.  Immunoregulatory molecules in patients with gestational diabetes mellitus.

Authors:  Karen Priscilla Tezotto Pendeloski; Rosiane Mattar; Maria Regina Torloni; Caio Perez Gomes; Sandra Maria Alexandre; Silvia Daher
Journal:  Endocrine       Date:  2015-03-10       Impact factor: 3.633

4.  Maternal floor infarction/massive perivillous fibrin deposition: a manifestation of maternal antifetal rejection?

Authors:  Roberto Romero; Amy Whitten; Steven J Korzeniewski; Nandor Gabor Than; Piya Chaemsaithong; Jezid Miranda; Zhong Dong; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  Am J Reprod Immunol       Date:  2013-08-01       Impact factor: 3.886

Review 5.  Postpartum group a Streptococcus sepsis and maternal immunology.

Authors:  Katie L Mason; David M Aronoff
Journal:  Am J Reprod Immunol       Date:  2011-10-24       Impact factor: 3.886

6.  Evidence for a role for the adaptive immune response in human term parturition.

Authors:  Nardhy Gomez-Lopez; Rodrigo Vega-Sanchez; Marisol Castillo-Castrejon; Roberto Romero; Karen Cubeiro-Arreola; Felipe Vadillo-Ortega
Journal:  Am J Reprod Immunol       Date:  2013-01-24       Impact factor: 3.886

7.  B7h (ICOS-L) maintains tolerance at the fetomaternal interface.

Authors:  Leonardo V Riella; Shirine Dada; Lola Chabtini; Brian Smith; Lei Huang; Pranal Dakle; Bechara Mfarrej; Francesca D'Addio; La-Tonya Adams; Nora Kochupurakkal; Andrea Vergani; Paolo Fiorina; Andrew L Mellor; Arlene H Sharpe; Hideo Yagita; Indira Guleria
Journal:  Am J Pathol       Date:  2013-04-08       Impact factor: 4.307

8.  β3-Adrenoceptors as Putative Regulator of Immune Tolerance in Cancer and Pregnancy.

Authors:  Maura Calvani; Annalisa Dabraio; Angela Subbiani; Daniela Buonvicino; Veronica De Gregorio; Sara Ciullini Mannurita; Alessandro Pini; Patrizia Nardini; Claudio Favre; Luca Filippi
Journal:  Front Immunol       Date:  2020-09-02       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.